Characterization of new monoclonal antibodies that discriminate between soluble and membrane CD4 and compete with human anti-CD4 autoimmune sera

Molecular Immunology

Volumn 40, Issue 5, 2003, Pages 231-239

  Denisova, Galina ^a   Lideman, Ludmila ^b   Spectorman, Evgenia ^a   Abulafia Lapid, Rivka ^c   Burke, Michael ^a   Yust, Israel ^a   Gershoni, Jonathan M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

AIDS; Antibody; Autoimmunity; CD4 receptor; Epitope

Indexed keywords

ANTISERUM; CD4 ANTIGEN; EPITOPE; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PROTEIN DOMAIN; SERUM; TRANSGENIC MOUSE;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS MUSCULUS;

EID: 0042427499     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(03)00147-0     Document Type: Article

References (43)

1. Blum M.D., Wong G.T., Higgins K.M., Sunshine M.J., Lacy E. Reconstitution of the subclass-specific expression of CD4 in thymocytes and peripheral T cells of transgenic mice: identification of a human CD4 enhancer. J. Exp. Med. 177:1993;1343-1358.
2. Broder C.C., Berger E.A. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion. J. Virol. 67:1993;913-926.
3. Callahan L.N., Roderiques G., Mallinson M., Norcross M.A. Analysis of HIV-induced autoantibodies to cryptic epitopes on human CD4. J. Immunol. 149:1992;2194-2202.
4. Chams V., Jouault T., Fenouillet E., Gluckman J.C., Klatzman D. Detection of anti-CD4 autoantibodies in the sear of HIV-infected patients using recombinant soluble CD4 molecules. AIDS. 2:1988;353-361.
5. Clayton L.K., Sieh M., Pious D.A., Reinherz E.L. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature. 339:1989;548.
6. Dalgleish A.G., Beverley P.C., Clapham P.R., Crawford D.H., Greaves M.F., Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:1984;763.
7. D'aloja P., Olivetta E., Bona R., Nappi F., Pedacchia D., Pugliese K., Ferrari G., Verani P., Federico M. gag, vif, and nef Genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants. J. Virol. 72:1998;4308-4319.
8. Denisova G., Stern B., Raviv D., Zwickel J., Smorodinsky N.I., Gershoni J.M. Humoral immune response to immunocomplexed HIV envelope glycoprotein 120. AIDS Res. Hum. Retroviruses. 12:1996;901-909.
9. Denisova G., Raviv D., Mondor I., Sattentau Q.J., Gershoni J.M. Conformational transitions in CD4 due to complexation with HIV envelope glycoprotein gp120. J. Immunol. 158(3):1997;1157-1164.
10. DeVico A.L. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 Gp120-CD4 receptor complex. J. Virol. 74:2000;11427-11436.
11. DeVico A.L., Rahman R., Welch J., Crowley R., Lusso P., Sarngadharan M.G., Pal R. Monoclonal antibodies raised against covalently cross-linked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp120. Virology. 211:1995;583-588.
12. DeVico A., Silver A., Thornton A.M., Sarngadharan M.G., Pal R. Covalently cross-linked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates. Virology. 218:1996;258-263.
13. Doyle C., Strominger J.L. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature. 330:1987;256.
14. Evans C.F., Horwitz M.S., Hobbs M.V., Oldstone M.B. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J. Exp. Med. 184:1996;2371-2384.
15. Fouts T.R., Tuskan R., Godfrey K., Reitz M., Hone D., Lewis G.K., DeVico A.L., Fouts T.R., Pal R., Miller N., Reitz M., Hone D., Lewis G.K., Gallo R. Immunogenic properties of HIV-1 gp120-CD4 complex. J. Hum. Virol. 4:2001;124.
16. Fujita K., Omura S., Silver J. Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 env and vpu is blocked by proteasome inhibitors. J. Gen. Virol. 78:1997;619-625.
17. Furci L., Beretta A., Siccardi A., Lazzarin A., Confetti C., Magnani Z., Scarpellini P., Lopalco L., Burastero S.E. Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 production in exposed uninfected subjects. AIDS Res. Hum. Retroviruses. 13:1997;1461-1469.
18. Gay D., Maddon P., Sekaly R., Talle M.A., Godfrey M., Long E., Galfre G., Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 73:1981;3-46.
19. Gershoni J.M., Denisova G., Raviv D., Smorodinsky N.I., Buyaner D. HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex. FASEB J. 7:1993;1185.
20. Goldstein G., Chess L., Axel R., Kappler J., Marrack J. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature. 328:1987;626.
21. Healey D., Dianda L., Moore J.P., McDougal J.S., Moore M.J., Estess P., Buck D., Kwong P.D., Beverley P.C.L., Sattentau Q.J. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4 cells from virus binding. J. Exp. Med. 172:1990;1273.
22. Kerkau T., Bacik I., Bennink J.R., Yewdell J.W., Hunig T., Schimpl A., Schubert U. The human immunodeficiency virus type 1 (HIV-1) vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J. Exp. Med. 185:1997;1295-1305.
23. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 312:1984;767.
24. Kowalski M., Ardman B., Basiripour L., Lu Y., Blohm D., Haseltine W., Sodroski J. Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 86:1989;3346-3350.
25. Li S., Satoh T., Korngold R., Huang Z. CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug design. Immunol. Today. 19:1998;455-462.
26. Manca F., Seravalli E., Valle M.T., Fenoglio D., Kunkl A., Li Pira G., Zolla-Pazner S., Celada F. Non-covalent complexes of HIV gp120 with CD4 and/or mAbs enhance activation of gp120-specific T clones and provide intermolecular help for anti-CD4 antibody production. Int. Immunol. 5(9):1993;1109.
27. Markus T., Moore J.P., Furman C., Charles M., Ho D.D., Robinson J., Sodroski J. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:1993;3978.
28. Moore J.P., Sattentau Q.J., Klasse P.J., Burkly L. A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4 cells. J. Virol. 66:1992;4784.
29. Ohashi P.S., Oehen S., Buerki K., Pircher H., Ohashi C.T., Odermatt B., Malissen B., Zinkernagel R.M., Hengartner H. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:1991;305-317.
30. Oldstone M.B., Nerenberg M., Southern P., Price J., Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell. 65:1991;319-331.
31. Olson J.K., Croxford J.L., Miller S.D. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol. 14:2001;227-250.
32. Paul M., Jabbar A.M. Phosphorylation of both phosphoacceptor sites in the HIV-1 vpu cytoplasmic domain is essential for vpu-mediated ER degradation of CD4. Virology. 232:1997;207-216.
33. Piguet V., Gu F., Foti M., Demaurex N., Gruenberg J., Carpentier J.-L., Trono D. Nef-induced CD4 degradation: a diacidic-based motif in nef functions as a lysosomal targeting signal through the binding of b-COP in endosomes. Cell. 97:1999;63-73.
34. Ryu S.E., Kwong P.D., Truneh A., Porter T.G., Arthos J., Rosenberg M., Dai X., Xuong N., Axel R., Sweet R.W., Hendrickson W.A. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature. 348:1990;418.
35. Schubert U., Bour S., Willey R.I., Strebel K. Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either vpu or env. J. Virol. 73:1999;887-896.
36. Seagal J., Spectorman E., Gershoni J.M., Denisova G.F. Use of human CD4 transgenic mice for studying immunogenicity of HIV-1 envelope protein gp120. Transgenic Res. 10:2001;113-120.
37. Sekigawa I., Groopmen J.E., Allan J.D., Ikeuchi K., Biberfield G., Takatsuki K., Byrn R.A. Characterization of autoantibodies to the CD4 molecule in human immunodeficiency virus infection. Clin. Immunol. Immunopathol. 58:1991;145-153.
38. Sweet R.W., Truneh A., Hendrickson W.A. CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological agent. Curr. Opin. Biotechnol. 2:1991;622.
39. Thirart C., Goudsmith J., Schellekens P., Barin F., Zagury D., De Wilde M., Bruck C. Antibodies to soluble CD4 in HIV-1 infected individuals. AIDS. 2:1988;345-351.
40. Vita C., Drakopoulou E., Vizzavona J., Rochette S., Martin L., Menez A., Roumestand C., Yang Y.S., Ylisastigui L., Benjouad A., Gluckman J.C. Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 96(23):1999;13091-13096.
41. von Herrath M.G., Evans C.F., Horwitz M.S., Oldstone M.B. Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system. Immunol. Rev. 152:1996;111-143.
42. Wang J., Yan Y., Garrett T.P., Liu J., Rodgers D.W., Garlick R.L., Tarr G.E., Husain Y., Reinherz E.L., Harrison S.C. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature. 348:1990;411.
43. Wu H., Kwong P.D., Hendrickson W.A. Dimeric association and segmental variability in the structure of human CD4. Nature. 387:1997;527-530.